Home
Site Map
Press Room
Contact Us
Press Releases
Clinical Trials
Phase 3 — Hepatocellular Carcinoma (HCC)
Phase 3 — Metastatic Colorectal Cancer (MCRC)
Phase 2 — Benign Prostatic Hyperplasia (BPH)
Phase 1 — Benign Prostatic Hyperplasia (BPH)
Pipeline
Hepatocellular Carcinoma (HCC)
Metastatic Colorectal Cancer (MCRC)
Glioma
Benign Prostatic Hyperplasia (BPH)
Aptocine™
Aptocine™ Advantages
Publications
The Company
Executive Team
Board of Directors
Scientific Advisory Board
Careers
Contact LSO
The Company
Executive Team
Llew Keltner
James Chen
Erik Hagstrom
Lisa Koch-Hulle
Robert Littauer
Sy-Shi Wang
Board of Directors
Scientific Advisory Board
Careers
Contact LSO
Executive Team
Llew Keltner
President, CEO and Director
James Chen
Chief Scientific Officer
Erik Hagstrom
VP Operations
Lisa Koch-Hulle
VP Regulatory Affairs
Robert Littauer
VP Chief Financial Officer
Sy-Shi Wang
VP Clinical Development